表紙
市場調查報告書

臨床試驗管理系統(CTMS)的全球市場

Clinical Trial Management Systems (CTMS)

出版商 Global Industry Analysts, Inc. 商品編碼 240200
出版日期 內容資訊 英文 250 Pages
商品交期: 最快1-2個工作天內
價格
臨床試驗管理系統(CTMS)的全球市場 Clinical Trial Management Systems (CTMS)
出版日期: 2019年01月01日內容資訊: 英文 250 Pages
簡介

本報告提供全球臨床試驗管理系統(CTMS)市場相關調查分析,各產品區隔、地區 (美國、加拿大、歐洲、亞太地區、南美、其他) ,市場成果與預測,包含主要企業簡介等系統性資訊。

第1章 簡介,調查手法,產品定義

第2章 摘要整理

  • 產業概要
    • CTMS優勢
    • CTMS的優點
    • 全球市場概要
  • 主要的成長促進因素與市場趨勢
    • 全球人口增加成為成長機會
    • 對研究開發的增資:重要的成長促進因素
    • 臨床試驗的全球化
    • CRO
    • 臨床試驗的複雜化等
  • CTMS:概要
    • 序文
    • 臨床試驗流程的簡略化
    • CTMS:核心能力
    • 計劃管理
    • CTMS的種類
    • 技術轉移等
  • 全球臨床試驗:概述
    • 概要
    • CRO所扮演的角色
  • 產品的介紹/革新
  • 近來產業活動
  • 全球主要企業
    • ArisGlobal, LLC (美國)
    • BioClinica, Inc. (美國)
    • Bio-Optronics, Inc. (美國)
    • DSG, Inc. (美國)
    • eResearch Technology, Inc. (美國)
    • IBM Watson Health (美國)
    • MedNet Solutions (美國)
    • Medidata Solutions (美國)
    • Nextrials, Inc. (美國)
    • Oracle Corp. (美國)
    • PAREXEL International Corp. (美國)
    • Trial By Fire Solutions, LLC (美國)
    • Veeva Systems, Inc. (美國)
    • Winchester Business Systems (美國)
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第4章 競爭情形

  • 企業簡介:62公司
    • 美國
    • 加拿大
    • 日本
    • 歐洲
    • 亞太地區 (日本以外)

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6222

This report analyzes the worldwide markets for Clinical Trial Management Systems (CTMS) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 62 companies including many key and niche players such as -

ArisGlobal, LLC
BioClinica, Inc.
Bio-Optronics, Inc.
DSG, Inc.
eResearch Technology, Inc.
IBM Watson Health

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Clinical Trial Management Systems (CTMS) Gain Ground
    • Table 1: Increase in R&D Costs of a New Approved Drug: 1980s to 2010s
  • Benefits Offered by CTMS
  • Global Market Overview
  • Clinical Trial Management Systems Market to Post Explosive Growth
    • Table 2: Increasing Clinical Trial Failure Rate: 1990 and 2010 (includes corresponding Graph/Chart)
  • Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
    • Increased Demand for Cloud-based and Other Advanced CTMS
    • Veeva Vault CTMS Gains Prominence
  • Key Players in the CTMS Market
    • Select Major Clinical Trial Management Systems (CTMS) Providers Worldwide
  • Developed Countries Rule the Market
  • Pharmaceutical Firms and CROs to Drive Adoption Rate
  • Noteworthy Transformations in the Global Clinical Trial Sector
    • Rising Significance of Data Aggregation
    • Innovative Predictive Modeling Systems
    • Enhanced Patient Enrollment
    • Attention on Patient Centricity
    • Table 3: Percentage of Companies Utilizing Advanced Technologies in Clinical Trials (includes corresponding Graph/Chart)
    • Table 4: Utilization of Advanced Technologies in Clinical Trials across North America and Europe (includes corresponding Graph/Chart)
    • Rising Importance of mHealth and Wearable Devices
    • Improving Clinical Trial Quality

2. SELECT GROWTH DRIVERS AND MARKET TRENDS

  • Surging Global Population Offers Increased Growth Opportunities
    • Table 5: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (In Million) (includes corresponding Graph/Chart)
  • Increased Spend on R&D - An Important Growth Driver
    • Table 6: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart)
    • Table 7: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2016E (includes corresponding Graph/Chart)
  • Clinical Trial Globalization Surges Demand for CTMS
    • Table 8: Total Number of Registered Clinical Studies: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
    • Table 9: Total Number of Registered Clinical Trials with Results posted Worldwide: 2010-2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
    • Table 10: Total Number of Studies based on Region: 2017 (As of December 11, 2017) (includes corresponding Graph/Chart)
  • CROs - The Targeted Customers for CTMS
    • Table 11: Leading CROs Worldwide by Revenue: 2016 (includes corresponding Graph/Chart)
  • Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand
    • Noteworthy Contracts of Major CROs
  • CROs Adept with New Technologies to See More Business in Future
  • Consolidation of CROs Rampant in the Pharmaceutical Sector
  • Rise in Clinical Trial Complexities Propels CTMS Demand
    • Table 12: Increasing Complexity of a Typical Phase 3 Clinical Trial: 2002 Vs. 2012
  • Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand
    • Table 13: Global Biopharma % R&D Outsourcing (2014-2020) (includes corresponding Graph/Chart)
    • Table 14: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals (includes corresponding Graph/Chart)
  • Adoption of Digital Technologies Gains Pace
  • Clinical Trial Operators Demand Efficient Data Management Platforms
  • DLB System's Solution with Data Management Tools
  • Systems Integration Becomes Imperative
  • Technological Innovations Drive Market Growth
  • MC10 Introduces BioStampRC System to Capture Clinical Trial Data
  • UF Health Cancer Center Unveils OnCore(r) Clinical Trials Management System
  • UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution

3. CLINICAL TRIAL MANAGEMENT SYSTEMS - AN OVERVIEW

  • Clinical Trial Management Systems: A Prelude
  • CTMS Eases Clinical Trials Process
  • Features/Benefits of a Typical CTMS
  • CTMS: Core Capabilities
  • Project Management
  • Subject and Site Management
  • Site and Clinical Trial Planning
  • Clinical Study Management
  • Financial/Payment Management
  • Investigator Management
  • Management of Supply Logistics
  • Study Documentation/Protocol Management
  • Reporting and Performance of Clinical Trial
  • Other Key Capabilities
  • Types of Clinical Trial Management Systems
  • Licensed Enterprise Solution
  • Web-Hosted Solution (CTMS SaaS)
    • Benefits of a Web-based CTMS
  • Technology Transfer
  • Key Features of an Effective CTMS
  • Major Users of CTMS
  • Functions of CTMS
  • For Pharma and Biotech Companies
  • For Research Sites, Government and Academic Institutions
  • For Contract Research Organizations
  • Integrated CTMS Gaining Prominence
  • Limitations of CTMS
  • Cost and Customization
  • Onus on Clinical Team
  • Implementation Issues
  • CTMS: Key Challenges
  • CTMS: Potential Benefits
  • Important Factors to be Considered while Selecting a CTMS
  • Regulatory Compliance
  • CDISC Standards

4. GLOBAL CLINICAL TRIALS - A SNAPSHOT

  • Overview
    • Table 15: Clinical Trials Breakdown Initiated in 2016 by Phase: In Percentage (includes corresponding Graph/Chart)
    • Table 16: Leading Industry Sponsors/Collaborators in 2016 (includes corresponding Graph/Chart)
    • Table 17: Leading Diseases of Phase I-III Clinical Trials Started in 2016 (includes corresponding Graph/Chart)
  • Role of Contract Research Organizations (CROs) in Clinical Activity
  • Major CROs with Internally Developed CTMS Systems
  • CRO Acquisitions: Clinical Trial Technologies

5. PRODUCT INTRODUCTIONS/INNOVATIONS

  • TCS Unveils Connected Clinical Trials
  • Trial by Fire Solutions Releases SimpleTrials 2.0
  • PAREXEL Unveils Patient Sensor Solution
  • ASCO & Friends of Cancer Research Launches Initiative to Modernize Eligibility Criteria for Clinical Trials
  • Medidata Launches New Payment Technology
  • ClinDatrix Unveils Oracle Health Sciences InForm 6.1 and Oracle Argus 8.0
  • Bioclinica Introduces OnPoint Direct CTMS
  • TransCelerate BioPharma Introduces SIP Technology
  • PAREXEL Introduces IMPACT Express CTMS
  • Veeva Systems Introduces Clinical Trials Study Startup Solution
  • Ottawa Hospital Introduces Clinical Trial of Double-Virus Cancer
  • Comprehend Systems Unveils Quality Solution for ClinOps
  • KCR S.A., Introduces Innovative Clinical Trial Data Platform

6. RECENT INDUSTRY ACTIVITY

  • OmniComm Systems Signs LOI to Acquire Algorics
  • Bio-Optronics Partners with Complion
  • Singota Solutions Enters into Partnership with Slope.io
  • Anju Software Acquires ClinPlus
  • Bio-Optronics and Adventist Health System Rolls out the Clinical Conductor CTMS
  • Medidata Partners with Karyopharm
  • ERT Secures 2016 Scrip Award
  • Medidata Solutions Provides Cloud Platform & Mobile Health Capabilities to Techfields Pharma
  • ICON Takes Over Clinical Research Management
  • Biomedical Systems Partners with Foundry Health
  • Medidata Cloud Technology Choosen to Support Biogen Clinical Trials
  • UPS Expands Healthcare-Specific Capabilities to Support Clinical Trials
  • PFS Clinical Partners with Velos
  • Green Circle Health Partners with Integrated Clinical Solutions
  • Pfizer Selects Oracle Cloud for Clinical Data Management and Trial Management
  • LSK Global PS Expands Use of Medidata Clinical Cloud Platform
  • Bioclinica Integrates with Parallel 6's Clinical Reach
  • FMD Adopts Oracle's Cloud-Based Clinical Data Management Solutions
  • Nextrials Presents New Opportunities for Healthcare Providers & Researchers
  • Medidata Expands Adoption of the Medidata Clinical Cloud
  • MedStar Health Collaborates with Forte Research Systems
  • PFS Clinical Partners with Clinical Conductor CTMS
  • Bioclinica Acquires Clinverse
  • ICON Takes Over PMG Research
  • BioClinica Integrates OnPoint CTMS with Clireo eTMF
  • eResearchTechnology, Inc.'s Insights Cloud Replaces Traditional CTMS Functionality
  • IBM Acquires Merge Healthcare
  • Guardian Research Network Collaborates with Molecular Health
  • Quintiles Enters into Definitive Agreement with Quest Diagnostics
  • Accenture Selects Medidata's Technology for Expansion of Cloud Capabilities for R&D
  • Medidata Partners with Peking University
  • PPDI Migrates CTMS to Oracle Health Sciences Cloud
  • CROS NT Partners with DATATRAK
  • Medidata partners with Garmin

7. FOCUS ON SELECT PLAYERS

  • ArisGlobal, LLC (USA)
  • BioClinica, Inc. (USA)
  • Bio-Optronics, Inc. (USA)
  • DSG, Inc. (USA)
  • eResearch Technology, Inc. (USA)
  • IBM Watson Health (USA)
  • MedNet Solutions (USA)
  • Medidata Solutions (USA)
  • Nextrials, Inc. (USA)
  • Oracle Corp. (USA)
  • PAREXEL International Corp. (USA)
  • Trial By Fire Solutions, LLC (USA)
  • Veeva Systems, Inc. (USA)
  • Winchester Business Systems (USA)

8. GLOBAL MARKET PERSPECTIVE

    • Table 18: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery Mode - Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery Mode - Percentage Breakdown of Revenues for Web-based CTMS, Cloud-based CTMS, and On-Premise CTMS Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • United States: The Largest Market for CTMS Worldwide
    • Table 24: The US Life Science R&D Spending: 2014 - 2016 (includes corresponding Graph/Chart)
    • Growing Demand from CROs Drives the CTMS Market
    • Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 25: The US Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 26: The US Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 27: Canadian Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: Canadian Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Clinical Trial Regulation to Strengthen EU's Presence in Clinical Research
    • EMA Focuses on Enhancing Patient Safety in First-In-Human Clinical Trials
    • Brexit Referendum to Threaten UK's Position as Leading Hub for Clinical Trials
    • Product Launch
  • B. Market Analytics
    • Table 29: European Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 30: European Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • R&D Outsourcing in Life Sciences on the Rise
    • Asia: The Most Preferred Destination for Clinical Trials
    • Table 31: Total Number of Clinical Studies Conducted in Asia: 2017 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 32: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 33: Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 34: Asia-Pacific 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

4a. CHINA

  • A. Market Analysis
    • China Rapidly Emerges as Compelling Destination for Clinical Trials
  • B. Market Analytics
    • Table 35: Chinese Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 36: Chinese Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

4b. REST OF ASIA PACIFIC

  • A. Market Analysis
    • Review of Select Markets
      • India
      • A Thriving Clinical Trials Market
      • Reasons for Outsourcing to India
      • Approval Process in India
      • Regulatory Issues
      • Improper Functioning of CROs
      • Clinical Study Liabilities
      • Access to Treatment Following Clinical Trial
      • Legislation to Monitor Drug Trials
      • FDA and WHO Issue Notices to Drug Makers Using Data from Indian CRO
      • Australia
      • Australia to Retain Position as Compelling Hub for Early-Phase Clinical Research
      • Initiatives Taken by Australian Government for Popularizing Clinical Trials
    • Product Approval
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 37: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 38: Rest of Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. LATIN AMERICA

  • A. Market Analysis
    • Latin America: An Emerging Market for Clinical Trials
  • B. Market Analytics
    • Table 39: Latin American Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 40: Latin American Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 41: Latin American 14-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

5a. BRAZIL

  • Market Analysis
    • Table 42: Brazilian Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 43: Brazilian Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

5b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 44: Rest of Latin American Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 45: Rest of Latin American Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • Market Analysis
    • Table 46: Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 47: Rest of World Historic Review for Clinical Trial Management Systems (CTMS) Market Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)